Research & academia
A new formulation method for your lab
EncapX® brings continuous supercritical CO₂ encapsulation to research labs: equipment you can fund on an equipment budget, and a method that opens new publications
The challenge
What holds formulation back today
- Microfluidic chips that clog and limit what you can test
- Results that do not translate to scale
- Limited access to industrial-grade tools
What EncapX® changes
A continuous answer
- Continuous, automated and reproducible
- Tunable parameters (pressure, temperature, flow rates) for systematic studies
- Results that transfer to industrial scale
- A growing body of peer-reviewed work
Typical actives
Payloads we encapsulate in this market
- formulations for publication
- method development
- process studies
Your development journey
Four stages, one continuous process
01 · Discover
A technical call and a presentation.
Technical call
02 · Test
A feasibility study on your formulations.
Feasibility study
03 · Equip
An EncapX® system in your lab, with training.
Lab system
04 · Collaborate
Joint projects and European R&D programmes.
Partnerships
Proof
Evidence for this market
- Peer-reviewed work with Aix-Marseille University
- 2023 siRNA paper in Journal of Drug Delivery Science and Technology
- 2024 docetaxel paper (European Meeting on Supercritical Fluids)
Who we work with
Universities · Research institutes · Core facilities
From first screens to manufacturing partners, the same process stays in place.
FAQ
Questions we hear often
Can EncapX® be funded on an equipment budget?
Yes, it is designed as lab equipment as well as an industrial system.
Is the method published?
Yes, see our publications page.
Do you offer training?
Yes, installation includes training and technical support.